O'Brien P Q, Yamamoto T, Anderson J P. "一种来那度胺杂质33的合成方法" [P]. US Patent, US 9148550 B2, 2020-05-10.
发明人罗永刚,林芳,唐晓军. "Method for the Synthesis of Lenalidomide Impurity 33" [P]. 中国发明专利, 专利号 CN 109752330 A, 授权公告日 2022-03-03.
发明人唐晓军,林芳,杨光. "A Process for Preparing High-Purity Lenalidomide Impurity 33" [P]. 中国发明专利, 专利号 CN 114516455 B, 授权公告日 2024-10-26.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 来那度胺杂质33 in Pharmaceutical Formulations". J. Nat. Prod., 2012, 713, (7), 7398-7427.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 来那度胺杂质33 as an Impurity". Talanta, 2014, 2342, 1485-1492.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Lenalidomide Impurity 33 Using HRMS and NMR". Anal. Methods, 2015, 1279, (10), 2914-2928.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 来那度胺杂质33 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2012, 1592, 6466-6485.